XOMA Corp.

XOMA Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.93
Market Cap
$131.91 M
Shares Outstanding
8.72 M
Public Float
7.76 M

Profile

Address
2200 Powell Street
Emeryville California 94608
United States
Employees -
Website http://www.xoma.com
Updated 07/08/2019
XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J.

Financials

View All

James R. Neal
Chief Executive Officer & Director
W. Denman van Ness
Chairman